Biopsy Devices Market Report 2023-2028 | Industry Trends, Share, Size, Growth and Opportunities
The latest report by IMARC Group, titled “ Biopsy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global biopsy devices market share. The global market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.66 Billion by 2028, exhibiting a growth rate (CAGR) of 6.60% during 2023-2028.
Biopsy devices play a pivotal role in the
field of medical diagnostics and healthcare. These specialized tools are
utilized by healthcare professionals to extract tissue samples from various
parts of the human body for further analysis. Biopsy procedures are critical in
diagnosing and assessing the presence of diseases, such as cancer, infections,
and other medical conditions. These devices are designed to ensure minimal
invasiveness while obtaining accurate tissue samples, making them an
indispensable component of the healthcare landscape.
For an in-depth analysis, you can refer sample
copy of the report: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Biopsy Devices Market Trends and
Drivers:
One of the primary drivers of market growth is
the increasing prevalence of cancer and other chronic diseases worldwide. As
the incidence of cancer continues to rise, the demand for biopsy procedures and
devices has surged. Healthcare providers are relying on biopsy devices to
obtain tissue samples that are essential for accurate cancer diagnosis,
staging, and treatment planning. This growing demand for biopsy devices is
expected to fuel market expansion in the coming years. Another noteworthy trend
in the global biopsy devices market is the constant innovation and advancement
in biopsy device technology. Manufacturers are continually striving to develop
more efficient and user-friendly devices. This includes the integration of
features like real-time imaging and guidance systems, which enhance the
precision and accuracy of biopsy procedures. Additionally, the development of
minimally invasive biopsy techniques, such as fine-needle aspiration and core
needle biopsy, has gained prominence. These techniques reduce patient
discomfort, recovery time, and healthcare costs, further driving the adoption
of biopsy devices. Besides, regulatory initiatives and approvals play a crucial
role in shaping the global biopsy devices market. Governments and regulatory
authorities are focusing on streamlining the approval process for new biopsy
devices while ensuring their safety and efficacy. This regulatory support
provides manufacturers with a clear path to market entry, fostering competition
and innovation in the industry, thus propelling the market growth.
Report Segmentation:
The report has segmented the market into the
following categories:
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound Guided Biopsy
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia,
Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia,
Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Argon Medical Devices
- Becton Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- CONMED Corporation
- Cook Group Incorporated
- Hologic Inc.
- INRAD Inc.
- Medtronic plc
Note: If you need specific information that is
not currently within the scope of the report, we will provide it to you as a
part of the customization.
About Us
IMARC Group is a leading market research
company that offers management strategy and market research worldwide. We
partner with clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major
market, scientific, economic and technological developments for business
leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and tourism, nanotechnology and
novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |
United Kingdom: +44-753-713-2163
Comments
Post a Comment